medical education - diabetes care...
TRANSCRIPT
Company Confidential
© 2011 Eli Lilly and Company
Medical Education - Diabetes Care Online
Lilly Egypt – Tamer Abbas
Lilly Mexico
1
Lilly DiabetesCompany Confidential
© 2011 Eli Lilly and Company
DCO opening remarks: Ryan Fuller
Company Confidential
© 2011 Eli Lilly and Company
Diabetes “E”ngagement initiative
Tamer Abbas
Colette Khaled
Nagla Fathy
Lilly DiabetesCompany Confidential
© 2011 Eli Lilly and Company
Background
“Diabetes care online” as service was not fully maximized by SF in 2012 (83
Physicians were engaged since its launch in Jan 2012)
According to 2012 statistics, number of visits was not incremental, and started
slowing down 3 months after the launch of the service due to lack of
continuous active promotion
The service was leveraged to HCPs based on no insights understanding,
resulting in low level of SF buy-in and consequently low HCP engagement
Minimal SOV was driven through digital channels in 2012
Lilly DiabetesCompany Confidential
© 2011 Eli Lilly and Company
What happened differently in 2013 to leverage on digital
engagement….
Meaningful insights enriched Diabetes Patient Journey;
“I need to receive better diabetes education to be able to better manage my patients”.
The high penetration level of internet usage in Egypt: recent data suggests
that Egypt is listed among the top 20 countries with highest number of internet
users worldwide
Successful Cross functional E-channel workshop was conducted early in
2013 to identify SOV driven from DCO: Achieve more than 3 fold increase in
HCP target users, from 83 in 2012 to 300 HCP by end of 2013 (50% target
list) digitally engaged with Lilly.
DCO is a non-clinical solution Lilly offers to HCPs who are seeking high
quality education.
5
Lilly DiabetesCompany Confidential
© 2011 Eli Lilly and Company
Diabetes “E”ngagement initiative Structure
Critical success factors:
– Share WHY? Are we deploying such an initiative, based on insights derived from
MOT patient journey.
– SF buy-in (How?)
Through high level of execution and passion behind the innovative service to Egyptian
Diabetes.
Selling DCO service in national meetings, articles summary twice monthly and results
summary per reps monthly
– HCP targeting workshop!
Measures of Success:
– HCPs Satisfaction survey by Vovici tool – planned end Q3
– Incremental number of Physicians users engaged with DCO: 300 users by end of
2013
– Incremental number of visits, a metric that shows consistent HCPs engagement with
the service, or active users
6
Lilly DiabetesCompany Confidential
© 2011 Eli Lilly and Company
0
20
40
60
80
100
120
140
# DCO Users - Egypt
Company Confidential
© 2011 Eli Lilly and Company
Diabetes Care Online Mexico
Valuable CME Support
2013 Planners Meeting
LCC. Indianapolis.
June 2013.
Lilly DiabetesCompany Confidential
© 2011 Eli Lilly and Company9
DCO Mexico
DCO promoted at Diabetologia 2013 DCO promoted at Endopeds Event2012
Delivering DCO at Medinfo Booth DCO promoted at Mix50 launch
Lilly DiabetesCompany Confidential
© 2011 Eli Lilly and Company10
DCO Mexico Metrics (May 2013)
Lilly DiabetesCompany Confidential
© 2011 Eli Lilly and Company11
DCO Mexico LEARNINGS
Targeting
– DCO is not for everyone -“VALUE” -
– Promoted in Top Customer
Lilly Events and Endo Congress
Booth & presentation
Also regional events MT Summit
2012-2013
Team work Medical/Marketing
– Medical Liaison Support (TL’s and
residents programs)
– Medical Advisor (Articles Reviewing)
Follow up
– Continue communication with
INFOMEDICA
– Sharing results month by month
Country Users
China 8081
MEXICO 717
India 532
Russia 507
Algeria 459
Top 5 DCO users
(May 2013)
DCO Value
– Multilingual (Spanish)
– Test/Certification
– E-mailing follow up